In recent times, the peptide known as SS-31, or elamipretide, has become a trending topic on social media platforms like TikTok, where users claim it may enhance their eyesight. Some individuals assert that this peptide has alleviated their astigmatism, a common visual impairment that causes blurriness.
One TikTok user remarked, "I want to see if my eyes are improving in some way on SS-31," noting a reduction in light sensitivity from screens. Others have reported improvements in their vision after a few weeks of use, with some claiming a measurable enhancement in their eyesight during recent eye exams.
Understanding SS-31
SS-31, a peptide composed of amino acids, is gaining traction in the wellness community. While it has FDA approval, its current application is limited to treating Barth syndrome, a rare mitochondrial disorder, rather than eye conditions. The use of SS-31 for visual enhancement is largely unregulated, and many are sourcing it through compounding pharmacies.
Scientific Perspectives on Vision Improvement
Despite the buzz, eye care professionals remain skeptical about SS-31's effectiveness for common vision issues. Notably, SS-31 is under investigation for its potential role in addressing age-related macular degeneration (AMD), but early studies have indicated that it may not meet the necessary efficacy benchmarks for this purpose.
Dr. Jeffrey Walline from The Ohio State University College of Optometry emphasizes that while SS-31 is being explored for AMD, it is not a solution for typical vision correction needs like nearsightedness or astigmatism. "Those problems are optical and structural," he explains, highlighting that a mitochondrial peptide is unlikely to reverse these conditions.
Dr. Raj Maturi, an ophthalmologist, echoes this sentiment, advising that individuals struggling with vision should seek professional medical evaluations rather than relying on viral trends or unproven supplements. Current options for vision correction include glasses, contact lenses, and surgical interventions.
Addressing a Growing Concern
The increasing prevalence of myopia, driven by prolonged screen time, has raised concerns among health professionals. According to the American Academy of Ophthalmology, myopia rates have surged significantly and are projected to reach 50% by 2050. This highlights the importance of addressing eye health through established medical practices rather than unverified supplements.
As research continues, the future of peptides like SS-31 in the realm of eye health remains uncertain. However, their potential to contribute to treatments for degenerative eye conditions could pave the way for innovative therapies as science progresses.